Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Details Narrative)

v3.8.0.1
Notes Payable (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Aug. 02, 2017
Mar. 21, 2017
Mar. 13, 2017
Mar. 07, 2017
Feb. 02, 2017
Nov. 03, 2016
Sep. 15, 2016
Mar. 31, 2016
Jun. 29, 2015
Feb. 03, 2015
Mar. 31, 2017
Feb. 28, 2017
Jan. 31, 2017
Aug. 31, 2016
Mar. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Consideration received               $ 5,000,000                  
Estimated value of accounts receivable               $ 8,700,000                  
Adjustment value of debt                               $ 0 $ 1,500,000
Investment percentage               20.00%                  
Debt term               6 months                  
Repayment of debt               $ 500,000                  
Debt instrument description               All payments recovered from the accounts receivable up to $5.25 million, if paid in full within six months, or $5.5 million, if not paid in full within six months, and (iii) 20% of all payments of the accounts receivable in excess of amounts received in (i) and (ii). On March 31, 2017, to the extent that the counterparty had not been paid $6.0 million, the Company was required to pay the difference.                  
Debt instrument periodic payment           $ 400,000                      
Warrant exercise per share                             $ 0.0038 $ 0.276  
Stock options exercise price per share                                
Loan outstanding                             $ 6,957,830 $ 6,957,830  
Alcimede LLC [Member]                                  
Due from related party                   $ 3,000,000              
Debt instrument maturity date                   Feb. 02, 2016              
Debt instrument interest rate                   6.00%              
Debt instrument extended due date Aug. 02, 2018                 Aug. 02, 2017              
Share based payment of exercised options granted                 66,667                
Stock options exercise price per share                 $ 37.50                
Loan outstanding                 $ 2,500,000           $ 168,500    
Repayment of common stock                           $ 300,000      
Mr Lagan [Member]                                  
Repayment of debt                     $ 50,000            
TCA Debenture [Member]                                  
Repayment of debt   $ 750,000                              
Accrued and unpaid interest   100,000     $ 400,000                        
Debt instrument fee   $ 150,000                              
Debt instrument maturity date   Jun. 27, 2017                              
TCA Debenture [Member] | April 2017 Through September 2017 [Member]                                  
Debt instrument periodic payment   $ 2,600,000                              
September 2016 Notes [Member]                                  
Debt instrument conversion price             $ 112.50                    
Warrant to purchase common stock             4,444                    
Warrant exercise per share             $ 180.00                    
Debt instrument maturity date             Mar. 15, 2017                    
Warrant exchanged shares of common stock     26,667                            
Christopher Diamantis [Member]                                  
Accrued and unpaid interest       $ 500,000               $ 500,000 $ 500,000        
Debt instrument face amount       $ 500,000                          
Warrant exercise per share       $ 15.00                          
Debt instrument interest rate                       10.00% 10.00%        
Two Investor [Member] | September 2016 Notes [Member]                                  
Debt instrument face amount             $ 400,000                    
Counterparty [Member]                                  
Investment percentage                             40.00%    
Due from related party                             $ 500,000    
Debt instrument fee                             $ 100,000    
Counterparty [Member] | Christopher Diamantis [Member]                                  
Investment percentage                             20.00%    
Due from related party                             $ 5,000,000    
Debt instrument fee                             $ 1,000,000